India to Dominican Republic: Ranitidine Export Trade Route
India has recorded 9 verified shipments of Ranitidine exported to Dominican Republic, representing a combined trade value of $105.7K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $11.7K USD. The leading Indian exporter is BALAXI VENTURES LIMITED, which accounts for 98% of total export value with 7 shipments worth $103.5K USD. On the buying side, BALAXI HEALTHCARE DOMINICANA SRL is the largest importer in Dominican Republic with $103.5K USD in purchases. The top 3 suppliers — BALAXI VENTURES LIMITED, SCOTT EDIL PHARMACIA LIMITED, TULSI MEDICAL & GENERAL STORES — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Dominican Republic Ranitidine corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $105.7K USD. The route is dominated by BALAXI VENTURES LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's ranitidine manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $11.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with ranitidine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 25.6%, placing it at rank #11 among India's top ranitidine export destinations globally.
On the import side, key buyers of Indian ranitidine in Dominican Republic include BALAXI HEALTHCARE DOMINICANA SRL, NIFARMED SRL, CONSIGNEE MASTER & OWNER OF GAZ AMA. BALAXI HEALTHCARE DOMINICANA SRL is the single largest importer with 7 shipments valued at $103.5K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ2
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#11
- Annual growth+25.6%
- Demand growth+23.4%
- Regulatory ease75/100
Top 10 Indian Ranitidine Exporters to Dominican Republic
Showing top 10 of 3 Indian suppliers exporting Ranitidine to Dominican Republic, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BALAXI VENTURES LIMITED Avg $14.8K per shipment | 7 | $103.5K | 98.0% |
| 2 | SCOTT EDIL PHARMACIA LIMITED Avg $2.1K per shipment | 1 | $2.1K | 2.0% |
| 3 | TULSI MEDICAL & GENERAL STORES Avg $1 per shipment | 1 | $1 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting ranitidine to Dominican Republic, ranked by total trade value. The listed exporters are: BALAXI VENTURES LIMITED, SCOTT EDIL PHARMACIA LIMITED, TULSI MEDICAL & GENERAL STORES. BALAXI VENTURES LIMITED is the dominant supplier with 7 shipments worth $103.5K USD, giving it a 98% market share.
Top 10 Ranitidine Importers in Dominican Republic
Showing top 10 of 3 known buyers in Dominican Republic receiving Ranitidine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ranitidine in Dominican Republic include BALAXI HEALTHCARE DOMINICANA SRL, NIFARMED SRL, CONSIGNEE MASTER & OWNER OF GAZ AMA. The largest importer is BALAXI HEALTHCARE DOMINICANA SRL, accounting for $103.5K USD across 7 shipments — representing 98% of all ranitidine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BALAXI HEALTHCARE DOMINICANA SRL | 7 | $103.5K | 98.0% |
| 2 | NIFARMED SRL | 1 | $2.1K | 2.0% |
| 3 | CONSIGNEE MASTER & OWNER OF GAZ AMA | 1 | $1 | 0.0% |
Top 10 Ranitidine Formulations Imported by Dominican Republic
Showing top 10 of 8 product formulations shipped on the India to Dominican Republic Ranitidine route, ranked by trade value
Dominican Republic imports a wide range of ranitidine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RANITIDINE 300 MG COATED TABLETS GSTIN-02AACCB8447R2Z8/TAX DOCUMENT NO.BT120/2324 PACKING-10X10 10000 TABS/CTN - 10X — accounts for $33.0K USD across 1 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RANITIDINE 300 MG COATED TABLETS GSTIN-02AACCB8447R2Z8/TAX DOCUMENT NO.BT120/2324 PACKING-10X10 10000 TABS/CTN - 10X | 1 | $33.0K | 31.2% |
| 2 | RANITIDINE 300 MG COATED TABLETS GSTIN- | 2 | $25.8K | 24.5% |
| 3 | RANITIDINE 300 MG COATED TABLETS GSTIN-02AACCB8447R2Z8/TAX DOCUMENT NO.BT093/2324 PACKING-10X10 10000 TABS/CTN - 10X | 1 | $13.4K | 12.7% |
| 4 | RANITIDINE 150 MG COATED TABLETS GSTIN- | 1 | $13.4K | 12.7% |
| 5 | RANITIDINE 150 MG COATED TABLETS GSTIN-02AACCB8447R2Z8/TAX DOCUMENT NO.BT107/2324 PACKING-10X10 10000 TABS/CTN - 10X | 1 | $9.3K | 8.8% |
| 6 | RANITIDINE 300 MG COATED TABLETS GSTIN-02AACCB8447R2Z8/TAX DOCUMENT NO.BT107/2324 PACKING-10X10 10000 TABS/CTN - 10X | 1 | $8.6K | 8.1% |
| 7 | PHARMACEUTICAL PRODUCT FORMULATION RANITIDINE HYDROCHLORIDE INJECTION 25MG/MLB NO.XA3F030 | 1 | $2.1K | 2.0% |
| 8 | RANTAC 300MG TABRANITIDINE TAB | 1 | $1 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 4 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's ranitidine exports to Dominican Republic are driven primarily by a handful of large-scale manufacturers. BALAXI VENTURES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Dominican Republic benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BALAXI VENTURES LIMITED, SCOTT EDIL PHARMACIA LIMITED, TULSI MEDICAL & GENERAL STORES — together account for 100% of total trade value on this route. The average shipment value of $11.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ranitidine 300 mg coated tablets gstin- and ranitidine 300 mg coated tablets gstin-02aaccb8447r2z8/tax document no.bt093/2324 packing-10x10 10000 tabs/ctn - 10x, suggesting that buyers in Dominican Republic tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BALAXI HEALTHCARE DOMINICANA SRL is the largest importer with 7 shipments worth $103.5K USD — representing 98% of all ranitidine imports from India on this route.
Route Statistics
- Trade Volume
- $105.7K
- Avg. Shipment
- $11.7K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~15 days
- Annual Growth
- +25.6%
Related Analysis
Other Ranitidine Routes
Unlock the Full India to Dominican Republic Ranitidine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Dominican Republic Ranitidine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ranitidine to Dominican Republic?
The leading Indian exporters of Ranitidine to Dominican Republic are BALAXI VENTURES LIMITED, SCOTT EDIL PHARMACIA LIMITED, TULSI MEDICAL & GENERAL STORES. BALAXI VENTURES LIMITED holds the largest market share at approximately 98% of total trade value on this route.
Q What is the total value of Ranitidine exports from India to Dominican Republic?
India exports Ranitidine to Dominican Republic worth approximately $105.7K USD across 9 recorded shipments. The average value per shipment is $11.7K USD.
Q Which ports does India use to ship Ranitidine to Dominican Republic?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 4 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Dominican Republic for Ranitidine?
The average transit time for Ranitidine shipments from India to Dominican Republic is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Dominican Republic Ranitidine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.6% with demand growth tracking at 23.4%. The route is ranked #11 among India's top Ranitidine export destinations globally.
Q How many suppliers are active on the India to Dominican Republic Ranitidine route?
There are currently 3 active Indian suppliers exporting Ranitidine to Dominican Republic. The market is moderately concentrated with BALAXI VENTURES LIMITED accounting for 98% of total shipment value.
Q Who are the main importers of Ranitidine from India in Dominican Republic?
The leading importers of Indian Ranitidine in Dominican Republic include BALAXI HEALTHCARE DOMINICANA SRL, NIFARMED SRL, CONSIGNEE MASTER & OWNER OF GAZ AMA. BALAXI HEALTHCARE DOMINICANA SRL is the largest buyer with 7 shipments worth $103.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Dominican Republic export trade corridor identified from Indian Customs (DGFT) records for Ranitidine.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Dominican Republic matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists